The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(3-methyl-6-(pyrrolidin-1-yl)benzo[g]pyrrolo[2,1-a]phthalazine-1,2-diyl)dimethanol ID: ALA4874361
PubChem CID: 155124447
Max Phase: Preclinical
Molecular Formula: C22H23N3O2
Molecular Weight: 361.45
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1c(CO)c(CO)c2c3cc4ccccc4cc3c(N3CCCC3)nn12
Standard InChI: InChI=1S/C22H23N3O2/c1-14-19(12-26)20(13-27)21-17-10-15-6-2-3-7-16(15)11-18(17)22(23-25(14)21)24-8-4-5-9-24/h2-3,6-7,10-11,26-27H,4-5,8-9,12-13H2,1H3
Standard InChI Key: SEKXKZGJJQQVFM-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 31 0 0 0 0 0 0 0 0999 V2000
11.4640 -4.4202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4629 -5.2398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1709 -5.6487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1691 -4.0114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8778 -4.4166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8785 -5.2356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5871 -5.6427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5815 -4.0064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2906 -4.4098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2923 -5.2335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7140 -4.4067 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.9991 -3.9941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7157 -5.2305 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0049 -5.6451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1794 -6.4493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9983 -6.5317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3296 -5.7785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9963 -3.1769 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1282 -5.6051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4100 -7.2376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6353 -7.0589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2272 -7.2340 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.8912 -7.8350 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.6545 -2.6966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3993 -1.9203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5820 -1.9231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3324 -2.7012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 10 2 0
9 8 2 0
8 5 1 0
9 10 1 0
9 12 1 0
10 14 1 0
13 11 1 0
11 12 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 13 1 0
12 18 1 0
17 19 1 0
16 20 1 0
15 21 1 0
20 22 1 0
21 23 1 0
18 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 18 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 361.45Molecular Weight (Monoisotopic): 361.1790AlogP: 3.53#Rotatable Bonds: 3Polar Surface Area: 61.00Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 1.40CX LogP: 3.26CX LogD: 3.26Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.55Np Likeness Score: -0.58
References 1. Chen TL, Patel AS, Jain V, Kuppusamy R, Lin YW, Hou MH, Su TL, Lee TC.. (2021) Discovery of Oral Anticancer 1,2-Bis(hydroxymethyl)benzo[g ]pyrrolo[2,1-a ]phthalazine Hybrids That Inhibit Angiogenesis and Induce DNA Cross-Links., 64 (17.0): [PMID:34459195 ] [10.1021/acs.jmedchem.0c01733 ]